alexa Is It Cost Effective To Pool Donations For Nucleic Acid Testing For HCV Screening In Blood Banks From High Prevalence Communities?
ISSN: 2155-9597

Journal of Bacteriology & Parasitology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading Please wait..

2nd International Congress on Bacteriology & Infectious Diseases
November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore, USA

Manal M Baddour
ScientificTracks Abstracts: J Bacteriol Parasitol
DOI: 10.4172/2155-9597.S1.006
Blood transfusion may transmit infections with serious consequences such as Hepatitis C virus (HCV). Blood banks worldwide are shifting to nucleic acid testing (NAT) for effective screening of blood donations for HCV and HIV. Since viremia precedes seroconversion by several weeks, tests that detect viral nucleic acids are more sensitive than serology and may reduce the window of infectivity by as much as 50 to 60 days for HCV. However, this has not yet been adopted nationwide in Egypt due to financial constraints. Egypt currently has the highest prevalence of HCV. Testing of pooled donor samples significantly reduces the number of tests required on a daily basis, the time to perform the testing, and the cost of testing per donation. The rise of HCV in plasma is very rapid, thus sample dilution inherent in pooling has a minimal impact on the sensitivity to detect window period viremic samples. Pooling samples makes molecular-based testing of blood donors feasible. The current study evaluates pooling schemes in a cohort of 12,000 donations to validate the possibility of avoiding the deleterious effects of transmitting HCV while maintaining cost effectiveness.
Manal M Baddour has completed her PhD in Alexandria University as a joint project with NAMRU-III. She is a Professor of Medical Microbiology and Immunology, director of the Diagnostic Microbiology Lab in Alexandria University, a Microbiology Consultant for 3 diagnostic hospital labs & Editorial board member of 3 international Journals. She has published a book and more than 29 papers in reputed journals. She has shared as PI or co-investigator in many research projects in Egypt and Saudi Arabia and supervised 17 Master and PhD theses. She takes interest particularly in HCV and MRSA.
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version